2000
DOI: 10.1016/s0021-9150(99)00395-0
|View full text |Cite
|
Sign up to set email alerts
|

Effects of age, gender, and lifestyle factors on plasma apolipoprotein A-IV concentrations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

5
11
4

Year Published

2004
2004
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(20 citation statements)
references
References 48 publications
5
11
4
Order By: Relevance
“…Together, these results indicate that the induction of apoA-IV expression that occurs in fasting or diabetes entails a common glucocorticoid-dependent mechanism. Consistent with these in vivo findings in mice, apoA-IV protein levels are increased in diabetic patients (49).…”
Section: Discussionsupporting
confidence: 80%
“…Together, these results indicate that the induction of apoA-IV expression that occurs in fasting or diabetes entails a common glucocorticoid-dependent mechanism. Consistent with these in vivo findings in mice, apoA-IV protein levels are increased in diabetic patients (49).…”
Section: Discussionsupporting
confidence: 80%
“…A weak independent correlation of plasma apoA-IV with apoA-I has been observed previously and may reflect the association of the two apo's on LpA-I:A-IV particles. 23 A significant correlation between apoA-IV and fasting plasma TG has been reported, but was not confirmed in this and in other studies. 4,17,33,34 The reasons for these conflicting results remain unclear.…”
Section: Discussioncontrasting
confidence: 77%
“…A weak positive correlation of plasma apoA-IV with BMI (r ¼ 0.17, Po0.05) was observed in a large group of middle-aged women. 23 In the present study, the marked reduction of plasma apoA-IV occurring during weight reduction did not correlate with the changes of RBMI or plasma leptin levels. This suggests that the decrease of plasma apoA-IV was not a direct effect of the reduction of body fat mass.…”
Section: Discussioncontrasting
confidence: 75%
“…Experimental studies in isolated pancreatic islets and Apoa4 knockout mice have already demonstrated that ApoA-IV has a glucose-lowering effect [40,41]. Interestingly, consistent with two small type 2 diabetes studies, individuals with manifest type 2 diabetes had increased ApoA-IV levels in our study, [42,43]. However, a sensitivity analysis which we conducted showed that ApoA-IV levels were not increased in diabetic individuals who did not take glucose-lowering medication.…”
Section: Discussionsupporting
confidence: 88%